PreTel Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $352K
Latest Deal Amount
  • Investors
  • 5

PreTel General Information

Description

Provider of monitoring and decision support methods designed for all stages of pregnancy. The company's monitoring system identifies independent contraction activity of individual regions of the uterus and permits for improved care in the preterm labor patient, managing the progress of labor at the time of delivery and safety to the admiration of induction therapy, enabling hospitals to improve both maternal and neonatal outcomes in the labor and delivery department and avoid unnecessary C-Section deliveries, post-delivery maternal hemorrhage, and expensive neonatal intensive care nursery stays.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Primary Office
  • 871 McCallie Avenue
  • Chattanooga, TN 37403
  • United States
+1 (423) 000-0000

PreTel Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PreTel Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 01-Jan-2019 $352K 00.000 Completed Generating Revenue
4. Early Stage VC 27-Dec-2017 00000 00.000 Completed Generating Revenue
3. Early Stage VC (Series A) 15-Mar-2017 00.00 00.000 00.00 Completed Generating Revenue
2. Seed Round 08-Jan-2016 $375K $450K 00000 Completed Generating Revenue
1. Seed Round 30-Mar-2015 $74.9K $74.9K 00000 Completed Startup
To view PreTel’s complete valuation and funding history, request access »

PreTel Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Seed 2 000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Seed 115,300 $0.000100 5% $0.65 $0.65 1x $0.65 6.43%
To view PreTel’s complete cap table history, request access »

PreTel Executive Team (3)

Name Title Board Seat Contact Info
Marc Finch Co-Founder & Chief Executive Officer
Roger Young MD Co-Founder, Chief Medical Officer & President
Mark Samuels Executive Chairman
To view PreTel’s complete executive team members history, request access »

PreTel Board Members (4)

Name Representing Role Since
Blake Patton Tech Square Venture Partners Board Member 000 0000
David Adair MD Solas BioVentures Board Member 000 0000
Gregg Raybuck PreTel Board Member 000 0000
Mark Samuels Self Executive Chairman 000 0000
To view PreTel’s complete board members history, request access »

PreTel Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
Solas BioVentures Venture Capital Minority 000 0000 000000 0
Foley Ventures Venture Capital Minority 000 0000 000000 0
Tech Square Venture Partners Venture Capital Minority 000 0000 000000 0
University of Tennessee Research Foundation Limited Partner Minority 000 0000 000000 0
To view PreTel’s complete investors history, request access »